<VariationArchive VariationID="1435455" VariationName="NM_003721.4(RFXANK):c.338-25_338del" VariationType="Deletion" Accession="VCV001435455" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1432740" VariationID="1435455">
      <GeneList>
        <Gene Symbol="RFXANK" FullName="regulatory factor X associated ankyrin containing protein" GeneID="8625" HGNC_ID="HGNC:9987" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="19192258" stop="19201866" display_start="19192258" display_stop="19201866" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="19303007" stop="19312677" display_start="19303007" display_stop="19312677" Strand="+" />
          </Location>
          <OMIM>603200</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003721.4(RFXANK):c.338-25_338del</Name>
      <CanonicalSPDI>NC_000019.10:19197495:GGTATTGCCCGCCTCCTCCTGCCAGG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="19197496" stop="19197521" display_start="19197496" display_stop="19197521" variantLength="26" positionVCF="19197495" referenceAlleleVCF="TGGTATTGCCCGCCTCCTCCTGCCAGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="19308305" stop="19308330" display_start="19308305" display_stop="19308330" variantLength="26" positionVCF="19308304" referenceAlleleVCF="TGGTATTGCCCGCCTCCTCCTGCCAGG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.19197496_19197521del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.19197496_19197521del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.19308305_19308330del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.19308305_19308330del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007432.1" sequenceAccession="NG_007432" sequenceVersion="1" change="g.10298_10323del">
            <Expression>NG_007432.1:g.10298_10323del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003721.4" sequenceAccession="NM_003721" sequenceVersion="4" change="c.338-25_338del" MANESelect="true">
            <Expression>NM_003721.4:c.338-25_338del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278727.2" sequenceAccession="NM_001278727" sequenceVersion="2" change="c.272-25_272del">
            <Expression>NM_001278727.2:c.272-25_272del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_134440.3" sequenceAccession="NM_134440" sequenceVersion="3" change="c.269-25_269del">
            <Expression>NM_134440.3:c.269-25_269del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370235.1" sequenceAccession="NM_001370235" sequenceVersion="1" change="c.335-25_335del">
            <Expression>NM_001370235.1:c.335-25_335del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370238.1" sequenceAccession="NM_001370238" sequenceVersion="1" change="c.338-25_338del">
            <Expression>NM_001370238.1:c.338-25_338del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370233.1" sequenceAccession="NM_001370233" sequenceVersion="1" change="c.338-25_338del">
            <Expression>NM_001370233.1:c.338-25_338del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370234.1" sequenceAccession="NM_001370234" sequenceVersion="1" change="c.272-25_272del">
            <Expression>NM_001370234.1:c.272-25_272del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370237.1" sequenceAccession="NM_001370237" sequenceVersion="1" change="c.335-25_335del">
            <Expression>NM_001370237.1:c.335-25_335del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370236.1" sequenceAccession="NM_001370236" sequenceVersion="1" change="c.335-25_335del">
            <Expression>NM_001370236.1:c.335-25_335del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278728.2" sequenceAccession="NM_001278728" sequenceVersion="2" change="c.269-25_269del">
            <Expression>NM_001278728.2:c.269-25_269del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_102" sequenceAccession="LRG_102">
            <Expression>LRG_102:g.10298_10323del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603200.0001" DB="OMIM" />
        <XRef Type="rs" ID="776752313" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00003" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003721.4(RFXANK):c.338-25_338del AND MHC class II deficiency" Accession="RCV001972273" Version="4">
        <ClassifiedConditionList TraitSetID="6425">
          <ClassifiedCondition DB="MedGen" ID="C2931418">MHC class II deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003721.4(RFXANK):c.338-25_338del AND MHC class II deficiency 2" Accession="RCV004577006" Version="1">
        <ClassifiedConditionList TraitSetID="1826">
          <ClassifiedCondition DB="MedGen" ID="C1859535">MHC class II deficiency 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003721.4(RFXANK):c.338-25_338del AND MHC class II deficiency 1" Accession="RCV004558747" Version="1">
        <ClassifiedConditionList TraitSetID="97974">
          <ClassifiedCondition DB="MedGen" ID="CN377826">MHC class II deficiency 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-24" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10803838</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16166641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21908431</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22524894</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22863278</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7951244</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8229525</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9806546</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6425" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="486" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bare lymphocyte syndrome 2</ElementValue>
                <XRef ID="C537079" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency, HLA class II negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA Class 2-Negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA CLASS II-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency</ElementValue>
                <XRef ID="MONDO:0008855" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bare Lymphocyte Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="824" />
                <XRef ID="824" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="572" DB="Orphanet" />
              <XRef ID="C2931418" DB="MedGen" />
              <XRef ID="MONDO:0008855" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS209920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="97974" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="76411" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency 1</ElementValue>
                <XRef ID="MONDO:0971005" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MHC2D1</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Symbol>
              <XRef ID="CN377826" DB="MedGen" />
              <XRef ID="MONDO:0971005" DB="MONDO" />
              <XRef Type="MIM" ID="209920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1826" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8785" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bare lymphocyte syndrome, type II, complementation group B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency 2</ElementValue>
                <XRef ID="MONDO:0971013" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MHC2D2</ElementValue>
                <XRef Type="MIM" ID="620815" DB="OMIM" />
              </Symbol>
              <XRef ID="C1859535" DB="MedGen" />
              <XRef ID="MONDO:0971013" DB="MONDO" />
              <XRef Type="MIM" ID="620815" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5068759" SubmissionDate="2022-10-13" DateLastUpdated="2022-11-05" DateCreated="2022-11-05">
        <ClinVarSubmissionID localKey="NM_003721.3:c.338-25_338del26|MedGen:C2931418" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002598759" DateUpdated="2022-11-05" DateCreated="2022-11-05" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9806546</ID>
          </Citation>
          <Comment>Variant summary: RFXANK c.338-25_338del26 is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: four predict the variant abolishes a 3 prime acceptor site. At least one publication reports experimental evidence that this variant may affect mRNA splicing. The variant allele was found at a frequency of 3.3e-05 in 243934 control chromosomes. c.338-25_338del26 has been reported in the literature in multiple individuals affected with Bare Lymphocyte Syndrome 2 - RFXANK Related. These data indicate that the variant is very likely to be associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003721.3:c.338-25_338del26</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931418" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12153506</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4227560" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="6032571|MedGen:C2931418" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002217405" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10803838</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16166641</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21908431</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10803838</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21908431</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22524894</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22863278</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21908431</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 6 (c.338-25_338del) of the RFXANK gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RFXANK are known to be pathogenic (PMID: 10803838, 16166641, 21908431). This variant is present in population databases (rs776752313, gnomAD 0.02%). This variant has been observed in individual(s) with MHC class II deficiency (PMID: 10803838, 21908431, 22524894, 22863278). It is commonly reported in individuals of North African ancestry (PMID: 21908431). This variant is also known as I5E6-25_I5E6+1del and 752delG-25. ClinVar contains an entry for this variant (Variation ID: 1435455). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.19308305_19308330del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931418" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27172" SubmissionDate="2003-06-23" DateLastUpdated="2024-05-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603200.0001_MHC CLASS II DEFICIENCY 2" title="RFXANK, 26-BP DEL, NT752_MHC CLASS II DEFICIENCY 2" />
        <ClinVarAccession Accession="SCV000027172" DateUpdated="2024-05-26" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In cell lines derived from 2 unrelated individuals (families Ab and Na) with MHC class II deficiency-2 (MHC2D2; 620815), Masternak et al. (1998) found a homozygous 26-bp deletion of genomic DNA that removed the splice acceptor site and the first nucleotide of exon 6 of the RFXANK gene. In 1 of these families (Na), reported by Lisowska-Grospierre et al. (1994), the parents were known to be consanguineous. In both families, homozygosity was confirmed by analysis of DNA from other family members.</Attribute>
              <Citation>
                <ID Source="PubMed">9806546</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7951244</ID>
              </Citation>
              <XRef DB="OMIM" ID="620815" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Wiszniewski et al. (2000) performed a mutation analysis in 20 additional patients belonging to complementation group B and detected the homozygous 26-bp deletion beginning with 752G in 17 patients, all of North African origin. A founder effect was documented, since all tested patients, except 1, displayed a common haplotype spanning the RFXANK locus. Most of the patients had been reported by Klein et al. (1993).</Attribute>
              <Citation>
                <ID Source="PubMed">10803838</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8229525</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <Name>RFXANK, 26-BP DEL, NT752</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">26-BP DEL, NT752</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603200.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MHC CLASS II DEFICIENCY 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9799146" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_003721.4:c.338-25_338del|OMIM:209920" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005049419" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003721.4:c.338-25_338del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="209920" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES_20231129_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9799146" TraitType="Disease" MappingType="XRef" MappingValue="209920" MappingRef="OMIM">
        <MedGen CUI="CN377826" Name="MHC class II deficiency 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4227560" TraitType="Disease" MappingType="XRef" MappingValue="C2931418" MappingRef="MedGen">
        <MedGen CUI="C2931418" Name="MHC class II deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27172" TraitType="Disease" MappingType="Name" MappingValue="MHC CLASS II DEFICIENCY 2" MappingRef="Preferred">
        <MedGen CUI="C1859535" Name="MHC class II deficiency 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5068759" TraitType="Disease" MappingType="XRef" MappingValue="C2931418" MappingRef="MedGen">
        <MedGen CUI="C2931418" Name="MHC class II deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

